Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

332
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
332
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

267
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
267
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

515
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
515
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

384
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
384
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

344
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
344
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

185
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
185

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic Cystic Neoplasm Due to Chronic Calcifying Pancreatitis in Peutz-Jeghers Syndrome.

Gastro hep advancesĀ·2026
Same author

Aging Enhances Serotonergic Signaling via 5-HT<sub>7</sub> Receptors Underlying Mechanical Alloknesis.

Aging cellĀ·2026
Same author

Blood IL-6 is a critical trigger of depressive symptoms in a mouse model for human atopic dermatitis.

Translational psychiatryĀ·2026
Same author

Association of Skin Dryness and Disease-related Parameters with Mechanical Alloknesis in Atopic Dermatitis: A Crosssectional and Prospective Cohort Study.

Acta dermato-venereologicaĀ·2026
Same author

Psychological stress delays inflammatory resolution and promotes sustained sensory sensitization during recovery from atopic dermatitis.

The Journal of investigative dermatologyĀ·2026
Same author

Konjac Ceramide Induces Semaphorin 3A Expression via the MAPK/AP-1 Signaling Axis and RORĪ± in Normal Human Epidermal Keratinocytes.

BiomoleculesĀ·2026

Related Experiment Video

Updated: Aug 10, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.3K

Association Between Inflammatory Bowel Disease and Pruritus.

Shiho Iwamoto1,2, Mitsutoshi Tominaga1,3, Yayoi Kamata1,3

  • 1Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Urayasu, Chiba, Japan.

Crohn'S & Colitis 360
|February 13, 2023
PubMed
Summary

Inflammatory bowel disease (IBD) patients frequently experience pruritus (itching) and dry skin, especially during active disease stages. This finding suggests potential new ways to predict and manage IBD symptoms.

Keywords:
atopic dermatitisdry skininflammatory bowel diseaseitchingpruritusskin barrier dysfunction

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.2K
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

425

Related Experiment Videos

Last Updated: Aug 10, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.3K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.2K
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

425

Area of Science:

  • Gastroenterology
  • Dermatology
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) is associated with various extraintestinal manifestations.
  • Pruritus is a common symptom in IBD patients, but its clinical association lacks robust evidence.
  • This study aimed to investigate the incidence and characteristics of pruritus in IBD patients.

Purpose of the Study:

  • To determine the prevalence of pruritus in patients with inflammatory bowel disease (IBD).
  • To assess the relationship between pruritus severity, disease activity, and skin barrier function in IBD.
  • To explore potential neuro-cutaneous links in IBD-associated pruritus.

Main Methods:

  • Surveyed 71 IBD outpatients (55 ulcerative colitis, 16 Crohn disease) and 39 healthy volunteers using a visual analogue scale (VAS) for pruritus.
  • Assessed skin barrier function via transepidermal water loss (TEWL) and stratum corneum hydration.
  • Examined intraepidermal nerve fiber density using immunohistochemistry in skin samples from ulcerative colitis patients.

Main Results:

  • IBD patients reported significantly higher pruritus VAS scores compared to healthy volunteers (P < 0.001).
  • Active stage IBD patients exhibited more severe pruritus and impaired skin barrier function (higher TEWL, lower hydration) than remission stage patients.
  • A correlation was found between pruritus severity and intraepidermal nerve fiber density in ulcerative colitis patients.

Conclusions:

  • Patients with inflammatory bowel disease, particularly those with active disease, commonly experience pruritus and dry skin.
  • These findings highlight the potential predictive and therapeutic implications for managing IBD symptoms.
  • The study suggests a link between IBD activity, skin barrier dysfunction, and pruritus, possibly involving neuro-cutaneous pathways.